A PharmaSphere Inc. subsidiary didn’t mislead the US Patent and Trademark Office to obtain the patent at the center of an ...
This marks our sixth FDA biosimilar approval, expanding our portfolio to provide more affordable therapies to patients in the U.S.," said Dr. Sang Jin Pak, President Fresenius Kabi Biopharma.
Fresenius SE issued a dividend for 2024 and forecast growth in earnings and sales for this year on higher fourth-quarter ...
The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi ... and the US, and the company ...
Learn about Fresenius Kabi India Pvt. Ltd in Pune ... Explore more about over 8069 Pharmaceutical Companies in India through our constantly updated list. Medindia Constantly updates the database.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results